董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Albert D. Bolles | 男 | Director | 60 | 未披露 | 未持股 | 2018-05-17 |
| Eric J. Rey | 男 | Director | 62 | 8.44万美元 | 未持股 | 2018-05-17 |
| Uday Garg | 男 | Director | 39 | 7.82万美元 | 未持股 | 2018-05-17 |
| Rajendra Ketkar | 男 | President, Chief Executive Officer and Director | 64 | 64.42万美元 | 未持股 | 2018-05-17 |
| Kevin Comcowich | 男 | Chairman of the Board and Director | 49 | 9.59万美元 | 未持股 | 2018-05-17 |
| Amy Yoder | 女 | Director | 51 | 7.76万美元 | 未持股 | 2018-05-17 |
| Gregory D. Waller | 男 | Director | 68 | 9.24万美元 | 未持股 | 2018-05-17 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Zhongjin Lu | 男 | Vice President of Product Development | 52 | 32.04万美元 | 未持股 | 2018-05-17 |
| Rajendra Ketkar | 男 | President, Chief Executive Officer and Director | 64 | 64.42万美元 | 未持股 | 2018-05-17 |
| Sarah Reiter | 女 | Chief Commercial Officer | 46 | 未披露 | 未持股 | 2018-05-17 |
| Matthew T. Plavan | 男 | Chief Financial Officer | 54 | 48.47万美元 | 未持股 | 2018-05-17 |
董事简历
中英对照 | 中文 | 英文- Albert D. Bolles
-
Albert D. Bolles，哲学博士，自2014年5月以来担任董事。他目前是ConAgra的执行副总裁，首席技术官和首席运营官。他领导ConAgra的研究、质量和创新和供应链组织。他于2006年加入ConAgra，担任研究、质量和创新的执行副总裁。在他的领导下，ConAgra的研究、质量和创新团队为市场带来了非常成功的产品，促使大量的业务增长。加入ConAgra之前，他领导百事饮料和食物（PepsiCo Beverages and Foods）的全球研发。他服务于几个专业顾问委员会，包括Grocery Manufacturers Association（GMA）科学监管委员会（Scientific Regulatory Committee），目前是the Trout Council/Food Science program（鳟鱼委员会/食品科学项目）的主席。他有食品科学的哲学博士学位和硕士学位，微生物学的学士学位，所有都来自密歇根州立大学（Michigan State University）。他拥有多项专利，因其对食品科学界的贡献而赢得了众多奖项。
Albert D. Bolles has been the President of Curation Foods, Inc. since August 10 2022. Prior to that role, Dr. Bolles served as Chief Executive Officer of Landec Corporation and has served as a member of the Board of Directors since May 2014. Dr. Bolles also currently serves on the Board of Directors of SunOpta, Inc NASDAQ:STKL, where he is a member of its Corporate Governance Committee, and serves as a director of Arcadia Biosciences, Inc. (NASDAQ:RKDA), where he is a member of its Nominating and Corporate Governance Committee. Prior to becoming Landec Corporation's President and CEO on May 23 2019 Dr. Bolles was Chairperson of Landec Corporation's ad hoc Food Innovation Committee and a member of Landec Corporation's Compensation and Nominating and Corporate Governance Committees. From April 2014 until August 2015 Dr. Bolles served as Executive Vice President, Chief Technology & Operations Officer of ConAgra Foods, Inc. (now Conagra Brands, Inc. (NYSE:CAG)) ("ConAgra"), a leading consumer products food company with net sales exceeding $16 billion. Prior to this role, Dr. Bolles was Executive Vice President, Research, Quality and Innovation for ConAgra, championing the development and execution of multiple new and improved products, realizing incremental growth for ConAgra and facilitating a multi-year pipeline to sustain and advance growth further. Prior to joining ConAgra in 2006 Dr. Bolles served as Vice President, Worldwide R&D for the Beverages and Foods division of PepsiCo, Inc. (NASDAQ:PEP), responsible for global R&D leadership for beverages (Pepsi, Gatorade, and Tropicana) and Quaker Foods including product, process, package and sensory R&D, Nutrition, Quality, and Scientific & Regulatory Affairs. His prior employment was with Gerber Foods for over 8 years with his last role being its R&D Director, overseeing infant and toddler global research and development. Dr. Bolles has a Ph.D. and Masters of Science in Food Science, and a Bachelor of Science in Microbiology, all from Michigan State University. - Albert D. Bolles，哲学博士，自2014年5月以来担任董事。他目前是ConAgra的执行副总裁，首席技术官和首席运营官。他领导ConAgra的研究、质量和创新和供应链组织。他于2006年加入ConAgra，担任研究、质量和创新的执行副总裁。在他的领导下，ConAgra的研究、质量和创新团队为市场带来了非常成功的产品，促使大量的业务增长。加入ConAgra之前，他领导百事饮料和食物（PepsiCo Beverages and Foods）的全球研发。他服务于几个专业顾问委员会，包括Grocery Manufacturers Association（GMA）科学监管委员会（Scientific Regulatory Committee），目前是the Trout Council/Food Science program（鳟鱼委员会/食品科学项目）的主席。他有食品科学的哲学博士学位和硕士学位，微生物学的学士学位，所有都来自密歇根州立大学（Michigan State University）。他拥有多项专利，因其对食品科学界的贡献而赢得了众多奖项。
- Albert D. Bolles has been the President of Curation Foods, Inc. since August 10 2022. Prior to that role, Dr. Bolles served as Chief Executive Officer of Landec Corporation and has served as a member of the Board of Directors since May 2014. Dr. Bolles also currently serves on the Board of Directors of SunOpta, Inc NASDAQ:STKL, where he is a member of its Corporate Governance Committee, and serves as a director of Arcadia Biosciences, Inc. (NASDAQ:RKDA), where he is a member of its Nominating and Corporate Governance Committee. Prior to becoming Landec Corporation's President and CEO on May 23 2019 Dr. Bolles was Chairperson of Landec Corporation's ad hoc Food Innovation Committee and a member of Landec Corporation's Compensation and Nominating and Corporate Governance Committees. From April 2014 until August 2015 Dr. Bolles served as Executive Vice President, Chief Technology & Operations Officer of ConAgra Foods, Inc. (now Conagra Brands, Inc. (NYSE:CAG)) ("ConAgra"), a leading consumer products food company with net sales exceeding $16 billion. Prior to this role, Dr. Bolles was Executive Vice President, Research, Quality and Innovation for ConAgra, championing the development and execution of multiple new and improved products, realizing incremental growth for ConAgra and facilitating a multi-year pipeline to sustain and advance growth further. Prior to joining ConAgra in 2006 Dr. Bolles served as Vice President, Worldwide R&D for the Beverages and Foods division of PepsiCo, Inc. (NASDAQ:PEP), responsible for global R&D leadership for beverages (Pepsi, Gatorade, and Tropicana) and Quaker Foods including product, process, package and sensory R&D, Nutrition, Quality, and Scientific & Regulatory Affairs. His prior employment was with Gerber Foods for over 8 years with his last role being its R&D Director, overseeing infant and toddler global research and development. Dr. Bolles has a Ph.D. and Masters of Science in Food Science, and a Bachelor of Science in Microbiology, all from Michigan State University.
- Eric J. Rey
-
Eric J. Rey是公司创始人之一，自2003年8月起担任总裁、首席执行官和董事。Rey管理农业研究、产品开发和商业化计划长达30多年，主要关注于农业生物技术食品、饲料和工业产品。创立公司之前，Rey担任Rockridge Group（一家管理咨询公司，主要关注农业生物技术行业）合伙人。在Rockridge 任职期间，Rey管理初创公司的战略合伙企业开发，包括开发基因，生物制药、营养食品、农作物保护、动物营养和健康，替代作物和工业产品。加入Rockridge之前，Rey在Calgene Inc.担任了17年的运营副总裁，其中还在Monsanto Company（后被Calgene收购）任职过2年。在Calgene and Monsanto任职的17年里，他负责建立和管理公司的运营、产品采购和农业基础设施。Rey持有戴维斯the University of California植物学理学学士学位。
Eric J. Rey has served as a director since June 2017. He is one of our founders and served as president and chief executive officer of our company from August 2003 until his resignation in February 2016. He also served as a member of our board of directors from 2005 until February 2016. Mr. Rey has served as a director of Phytelligence, Inc. since 2015 as a director and a member of the compensation committee of Texas Crop Science, LLC since 2016 and as a director of Microprep Technologies since April 2018. Prior to founding our company, Mr. Rey worked as a partner with Rockridge Group, a management consulting firm, to manage the development of strategic partnerships for early-stage companies developing genomic, biopharmaceutical, nutraceutical, crop protection, animal nutrition and health, alternative crop, and industrial products. Prior to his work with Rockridge, Mr. Rey served as vice president of operations with Calgene Inc. for 17 years, including two years with Monsanto Company following its acquisition of Calgene. During his 17 years at Calgene and Monsanto, he was responsible for the establishment and management of the company's operational, product development, and agricultural infrastructure. Mr. Rey holds a Bachelor of Science in Plant Science from the University of California, Davis. - Eric J. Rey是公司创始人之一，自2003年8月起担任总裁、首席执行官和董事。Rey管理农业研究、产品开发和商业化计划长达30多年，主要关注于农业生物技术食品、饲料和工业产品。创立公司之前，Rey担任Rockridge Group（一家管理咨询公司，主要关注农业生物技术行业）合伙人。在Rockridge 任职期间，Rey管理初创公司的战略合伙企业开发，包括开发基因，生物制药、营养食品、农作物保护、动物营养和健康，替代作物和工业产品。加入Rockridge之前，Rey在Calgene Inc.担任了17年的运营副总裁，其中还在Monsanto Company（后被Calgene收购）任职过2年。在Calgene and Monsanto任职的17年里，他负责建立和管理公司的运营、产品采购和农业基础设施。Rey持有戴维斯the University of California植物学理学学士学位。
- Eric J. Rey has served as a director since June 2017. He is one of our founders and served as president and chief executive officer of our company from August 2003 until his resignation in February 2016. He also served as a member of our board of directors from 2005 until February 2016. Mr. Rey has served as a director of Phytelligence, Inc. since 2015 as a director and a member of the compensation committee of Texas Crop Science, LLC since 2016 and as a director of Microprep Technologies since April 2018. Prior to founding our company, Mr. Rey worked as a partner with Rockridge Group, a management consulting firm, to manage the development of strategic partnerships for early-stage companies developing genomic, biopharmaceutical, nutraceutical, crop protection, animal nutrition and health, alternative crop, and industrial products. Prior to his work with Rockridge, Mr. Rey served as vice president of operations with Calgene Inc. for 17 years, including two years with Monsanto Company following its acquisition of Calgene. During his 17 years at Calgene and Monsanto, he was responsible for the establishment and management of the company's operational, product development, and agricultural infrastructure. Mr. Rey holds a Bachelor of Science in Plant Science from the University of California, Davis.
- Uday Garg
-
Uday Garg，他是我们公司的董事（2014年6月以来）。他曾于2008年创立Mandala Capital公司（私人股本基金），也曾担任董事总经理兼董事（公司创立以来）。任职Mandala公司期间，他任职于Mandala公司的多个投资组合公司的董事会、附属的投资工具。此前，他曾担任Duet Group、Altima Partners、Amaranth Advisors公司投资经理。他的职业生涯始于担任Deutsche Bank的企业融资和并购部门的投资银行家。他持有宾夕法尼亚大学的沃顿商学院（the Wharton School of the University of Pennsylvania）的经济学学士学位（主修财务）。
Uday Garg has as served as a director since June 2014. He has also served as a director of Jain Fresh Foods Limited, India since March 2016. Mr. Garg founded Mandala Capital, a private equity fund, in 2008 and has served as managing director and a director since its inception. As part of his duties at Mandala, Mr. Garg serves on the boards of various Mandala portfolio companies and affiliated investment vehicles. Previously, Mr. Garg was a portfolio manager at Duet Group, Altima Partners, and Amaranth Advisors. He began his career as an investment banker in the corporate finance and mergers and acquisitions department of Deutsche Bank. He holds a Bachelor of Science in Economics with a concentration in finance from the Wharton School of Business at the University of Pennsylvania. - Uday Garg，他是我们公司的董事（2014年6月以来）。他曾于2008年创立Mandala Capital公司（私人股本基金），也曾担任董事总经理兼董事（公司创立以来）。任职Mandala公司期间，他任职于Mandala公司的多个投资组合公司的董事会、附属的投资工具。此前，他曾担任Duet Group、Altima Partners、Amaranth Advisors公司投资经理。他的职业生涯始于担任Deutsche Bank的企业融资和并购部门的投资银行家。他持有宾夕法尼亚大学的沃顿商学院（the Wharton School of the University of Pennsylvania）的经济学学士学位（主修财务）。
- Uday Garg has as served as a director since June 2014. He has also served as a director of Jain Fresh Foods Limited, India since March 2016. Mr. Garg founded Mandala Capital, a private equity fund, in 2008 and has served as managing director and a director since its inception. As part of his duties at Mandala, Mr. Garg serves on the boards of various Mandala portfolio companies and affiliated investment vehicles. Previously, Mr. Garg was a portfolio manager at Duet Group, Altima Partners, and Amaranth Advisors. He began his career as an investment banker in the corporate finance and mergers and acquisitions department of Deutsche Bank. He holds a Bachelor of Science in Economics with a concentration in finance from the Wharton School of Business at the University of Pennsylvania.
- Rajendra Ketkar
-
Rajendra Ketkar自2016年5月起担任公司总裁兼首席执行官。他的职位包括印度Mahyco-Monsanto Biotech合资企业的董事总经理和生物技术战略董事。Ketkar先生拥有俄克拉荷马州立大学（Oklahoma State University）化学工程硕士学位和新奥尔良大学（University of New Orleans）工商管理硕士学位。
Rajendra Ketkar has served as our president and chief executive officer since May 2016. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a Master of Business Administration from the University of New Orleans. - Rajendra Ketkar自2016年5月起担任公司总裁兼首席执行官。他的职位包括印度Mahyco-Monsanto Biotech合资企业的董事总经理和生物技术战略董事。Ketkar先生拥有俄克拉荷马州立大学（Oklahoma State University）化学工程硕士学位和新奥尔良大学（University of New Orleans）工商管理硕士学位。
- Rajendra Ketkar has served as our president and chief executive officer since May 2016. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a Master of Business Administration from the University of New Orleans.
- Kevin Comcowich
-
Kevin Comcowich自2016年11月起担任董事，自2017年11月起担任董事会主席。他最近担任德克萨斯州休斯敦HTX Energy Fund的首席执行官和投资组合经理。他此前曾担任Sound Energy Partners公司的总裁兼首席投资官首席信息官，也曾担任Southport Energy Plus Partners Fund公司的首席信息官兼研究分析师。Comcowich先生在印第安纳大学（University of Indiana）获得工商管理硕士学位，并在圣十字学院（College of the Holy Cross）获得学士学位。
Kevin Comcowich has served as a director since November 2016 and the chair of the board of directors since November 2017. He has most recently served as the chief executive officer and portfolio manager of HTX Energy Fund in Houston, Texas. He was previously the president and chief investment officer CIO of Sound Energy Partners and served as CIO and research analyst for Southport Energy Plus Partners Fund. Mr. Comcowich received his Master of Business Administration from the University of Indiana and earned his bachelor’s degree from the College of the Holy Cross. - Kevin Comcowich自2016年11月起担任董事，自2017年11月起担任董事会主席。他最近担任德克萨斯州休斯敦HTX Energy Fund的首席执行官和投资组合经理。他此前曾担任Sound Energy Partners公司的总裁兼首席投资官首席信息官，也曾担任Southport Energy Plus Partners Fund公司的首席信息官兼研究分析师。Comcowich先生在印第安纳大学（University of Indiana）获得工商管理硕士学位，并在圣十字学院（College of the Holy Cross）获得学士学位。
- Kevin Comcowich has served as a director since November 2016 and the chair of the board of directors since November 2017. He has most recently served as the chief executive officer and portfolio manager of HTX Energy Fund in Houston, Texas. He was previously the president and chief investment officer CIO of Sound Energy Partners and served as CIO and research analyst for Southport Energy Plus Partners Fund. Mr. Comcowich received his Master of Business Administration from the University of Indiana and earned his bachelor’s degree from the College of the Holy Cross.
- Amy Yoder
-
2012年5月以来， Amy Yoder一直是公司的董事。她是President of Arysta LifeScience North America, LLC（世界上最大的私营作物保护和生命科学公司）的首席执行官兼总裁。在2010年加入Arysta的五年多前，她有很多经验，包括：Atlas Advisors, LLC的高级顾问、Spectrum Brands, Inc的美国区主席、Chemtura, Inc的副主席和常务董事、Nufarm Ltd的副主席、The United Agri Productsd的UAPTimberland分区主席和北美品牌经理和当地的孟山都公司全国销售经理和的市场经理。
Amy Yoder is the President and CEO of Anuvia Plant Nutrients, an enhanced efficiency fertilizer company.Prior to joining Anuvia in 2015 she served as CEO and President of Arysta LifeScience North America, LLC, a division of the world's largest privately held crop protection and life science company from 2010 to 2015.Prior to joining Arysta, Ms. Yoder's experience included positions as a senior advisor to Atlas Advisors, LLC; president of the United Industries division of Spectrum Brands, Inc.; vice president and general manager for Biolab of Chemtura, Inc.; vice president of the turf and specialty division of Nufarm Ltd.; president of the UAP Timberland division of United Agri Products; and North American brand manager and national sales manager at Monsanto. - 2012年5月以来， Amy Yoder一直是公司的董事。她是President of Arysta LifeScience North America, LLC（世界上最大的私营作物保护和生命科学公司）的首席执行官兼总裁。在2010年加入Arysta的五年多前，她有很多经验，包括：Atlas Advisors, LLC的高级顾问、Spectrum Brands, Inc的美国区主席、Chemtura, Inc的副主席和常务董事、Nufarm Ltd的副主席、The United Agri Productsd的UAPTimberland分区主席和北美品牌经理和当地的孟山都公司全国销售经理和的市场经理。
- Amy Yoder is the President and CEO of Anuvia Plant Nutrients, an enhanced efficiency fertilizer company.Prior to joining Anuvia in 2015 she served as CEO and President of Arysta LifeScience North America, LLC, a division of the world's largest privately held crop protection and life science company from 2010 to 2015.Prior to joining Arysta, Ms. Yoder's experience included positions as a senior advisor to Atlas Advisors, LLC; president of the United Industries division of Spectrum Brands, Inc.; vice president and general manager for Biolab of Chemtura, Inc.; vice president of the turf and specialty division of Nufarm Ltd.; president of the UAP Timberland division of United Agri Products; and North American brand manager and national sales manager at Monsanto.
- Gregory D. Waller
-
Gregory D. Waller ，他是Sunshine Heart公司的董事（2011年8月以来）。他也任职Endologix Corporation（上市公司）的董事会，目前担任审计委员会主席和提名和治理委员会成员，也是Ulthera公司（一个私营公司，销售超声波设备，用于非侵入性眉部）的首席财务官。从2006年3月到2011年4月，他曾担任Universal Building Products公司（混凝土施工配件制造商）的首席财务官。他曾担任Sybron Dental Specialties公司（牙科产品消费品的制造商和销售商）的财务副总裁、首席财务官和财务主管（从1993年8月到2005年5月退休）。他也曾担任Kerr公司、Ormco Corporation、Metrex公司的副总裁兼财务主管。他于1980年12月加入Ormco Corporation，担任副总裁、总会计师。他也曾担任Kerr European公司的运营副总裁（从1989年7月到1993年8月）。他持有加州州立大学富勒顿分校（California State University, Fullerton）的工商管理硕士学位（会计）。他也曾任职几家私人公司的董事，涉及Alsius Corporation（一个上市公司，担任审计委员会主席和薪酬委员会的成员（从2007年6月到2009年9月被Zoll Medical Corporation收购）、 Biolase Technology公司（一家上市公司，担任审计委员会的主席）（从2009年10月到2010年8月）、 Cardiogenesis Corporation（公开交易的公司，公开交易的公司）、（从2007年4月到2011年5月被Cryolife公司收购）、Clarient公司（上市公司，于2010年12月被General Electric Company收购，担任审计委员会主席、薪酬和公司治理委员会的成员）（从2006年12月到2010年12月），SenoRx公司（一个于2010年7月被C.R.Bard公司收购的上市公司，担任审计委员会主席）（从2006年5月到2010年7月）。
Gregory D. Waller has served on our board of directors since November 2003. From October 2011 to April 2015 Mr. Waller was Chief Financial Officer of Ulthera Corp., a manufacturer of ultrasound equipment used to tighten and tone skin. Prior to that, from March 2006 to April 2011 Mr. Waller was Chief Financial Officer of Universal Building Products, a manufacturer of concrete construction accessories. Mr. Waller served as Vice President-Finance, Chief Financial Officer and Treasurer of Sybron Dental Specialties, Inc., a manufacturer and marketer of consumable dental products, from August 1993 until his retirement from Syborn in May 2005 and was formerly the Vice President and Treasurer of Kerr, Ormco Corporation, and Metrex. Mr. Waller joined Ormco Corporation in December 1980 as Vice President and Controller and served as Vice President of Kerr European Operations from July 1989 to August 1993. Mr. Waller also served on the board of directors and audit committee of Cardiogenesis Corporation, a publicly-traded company until its acquisition by Cryolife in 2011. Mr. Waller also served on the boards of directors of Alsius Corporation, a publicly-traded company, from June 2007 to September 2009 until its acquisition by Zoll, Biolase Technology, Inc., a publicly-traded company, from October 2009 to August 2010 Clarient, Inc., a publicly-traded company which was acquired by General Electric Company in December 2010 and SenoRx, Inc., a publicly-traded company which was acquired by C.R. Bard, Inc. in July 2010. Mr. Waller also serves on the boards of CHF Solutions and Arcadia Bioscience Corporation, both publicly-traded companies. Mr. Waller has an M.B.A. with a concentration in Accounting from California State University, Fullerton and a B.A. in Political Science from California State University, Fullerton. - Gregory D. Waller ，他是Sunshine Heart公司的董事（2011年8月以来）。他也任职Endologix Corporation（上市公司）的董事会，目前担任审计委员会主席和提名和治理委员会成员，也是Ulthera公司（一个私营公司，销售超声波设备，用于非侵入性眉部）的首席财务官。从2006年3月到2011年4月，他曾担任Universal Building Products公司（混凝土施工配件制造商）的首席财务官。他曾担任Sybron Dental Specialties公司（牙科产品消费品的制造商和销售商）的财务副总裁、首席财务官和财务主管（从1993年8月到2005年5月退休）。他也曾担任Kerr公司、Ormco Corporation、Metrex公司的副总裁兼财务主管。他于1980年12月加入Ormco Corporation，担任副总裁、总会计师。他也曾担任Kerr European公司的运营副总裁（从1989年7月到1993年8月）。他持有加州州立大学富勒顿分校（California State University, Fullerton）的工商管理硕士学位（会计）。他也曾任职几家私人公司的董事，涉及Alsius Corporation（一个上市公司，担任审计委员会主席和薪酬委员会的成员（从2007年6月到2009年9月被Zoll Medical Corporation收购）、 Biolase Technology公司（一家上市公司，担任审计委员会的主席）（从2009年10月到2010年8月）、 Cardiogenesis Corporation（公开交易的公司，公开交易的公司）、（从2007年4月到2011年5月被Cryolife公司收购）、Clarient公司（上市公司，于2010年12月被General Electric Company收购，担任审计委员会主席、薪酬和公司治理委员会的成员）（从2006年12月到2010年12月），SenoRx公司（一个于2010年7月被C.R.Bard公司收购的上市公司，担任审计委员会主席）（从2006年5月到2010年7月）。
- Gregory D. Waller has served on our board of directors since November 2003. From October 2011 to April 2015 Mr. Waller was Chief Financial Officer of Ulthera Corp., a manufacturer of ultrasound equipment used to tighten and tone skin. Prior to that, from March 2006 to April 2011 Mr. Waller was Chief Financial Officer of Universal Building Products, a manufacturer of concrete construction accessories. Mr. Waller served as Vice President-Finance, Chief Financial Officer and Treasurer of Sybron Dental Specialties, Inc., a manufacturer and marketer of consumable dental products, from August 1993 until his retirement from Syborn in May 2005 and was formerly the Vice President and Treasurer of Kerr, Ormco Corporation, and Metrex. Mr. Waller joined Ormco Corporation in December 1980 as Vice President and Controller and served as Vice President of Kerr European Operations from July 1989 to August 1993. Mr. Waller also served on the board of directors and audit committee of Cardiogenesis Corporation, a publicly-traded company until its acquisition by Cryolife in 2011. Mr. Waller also served on the boards of directors of Alsius Corporation, a publicly-traded company, from June 2007 to September 2009 until its acquisition by Zoll, Biolase Technology, Inc., a publicly-traded company, from October 2009 to August 2010 Clarient, Inc., a publicly-traded company which was acquired by General Electric Company in December 2010 and SenoRx, Inc., a publicly-traded company which was acquired by C.R. Bard, Inc. in July 2010. Mr. Waller also serves on the boards of CHF Solutions and Arcadia Bioscience Corporation, both publicly-traded companies. Mr. Waller has an M.B.A. with a concentration in Accounting from California State University, Fullerton and a B.A. in Political Science from California State University, Fullerton.
高管简历
中英对照 | 中文 | 英文- Zhongjin Lu
Zhongjin Lu， 他是我们的产品开发副总裁（2010年5月以来）。他此前曾担任我们的产品开发、植物育种董事（我们创立以来）。加入我们的公司之前，他曾担任Seaphire International公司（亚利桑那州海水农业公司）的植物育种董事，以及高级研究员。任职Seaphire公司之前，他曾任职Monsanto Company，在那里他曾负责盐碱农业的海蓬子属植物遗传改良项目。任职Monsanto Company之前，他曾任职江苏省农业科学院（the Jiangsu Academy of Agricultural Sciences）。他持有中国南京农业大学（Nanjing Agricultural University）的植物遗传和育种硕士学位，以及Technion-Israel Institute of Technology的植物生理学博士学位。
Zhongjin Lu, Ph.D. has served as our vice president of product development since February 2010. Dr. Lu has been with Arcadia since its inception, first as director of product development and plant breeding, and, since May 2010 as vice president of product development. Prior to joining Arcadia, Dr. Lu was the director of plant breeding and senior scientist at Seaphire International, Inc., a seawater-based agricultural company. Previously, he was employed by Monsanto Company and the University of Arizona, and he was associated with the Jiangsu Academy of Agricultural Sciences in China. Dr. Lu holds a master’s degree in plant genetics and breeding from Nanjing Agricultural University in China and a doctorate in plant physiology from Technion - Israel Institute of Technology.- Zhongjin Lu， 他是我们的产品开发副总裁（2010年5月以来）。他此前曾担任我们的产品开发、植物育种董事（我们创立以来）。加入我们的公司之前，他曾担任Seaphire International公司（亚利桑那州海水农业公司）的植物育种董事，以及高级研究员。任职Seaphire公司之前，他曾任职Monsanto Company，在那里他曾负责盐碱农业的海蓬子属植物遗传改良项目。任职Monsanto Company之前，他曾任职江苏省农业科学院（the Jiangsu Academy of Agricultural Sciences）。他持有中国南京农业大学（Nanjing Agricultural University）的植物遗传和育种硕士学位，以及Technion-Israel Institute of Technology的植物生理学博士学位。
- Zhongjin Lu, Ph.D. has served as our vice president of product development since February 2010. Dr. Lu has been with Arcadia since its inception, first as director of product development and plant breeding, and, since May 2010 as vice president of product development. Prior to joining Arcadia, Dr. Lu was the director of plant breeding and senior scientist at Seaphire International, Inc., a seawater-based agricultural company. Previously, he was employed by Monsanto Company and the University of Arizona, and he was associated with the Jiangsu Academy of Agricultural Sciences in China. Dr. Lu holds a master’s degree in plant genetics and breeding from Nanjing Agricultural University in China and a doctorate in plant physiology from Technion - Israel Institute of Technology.
- Rajendra Ketkar
Rajendra Ketkar自2016年5月起担任公司总裁兼首席执行官。他的职位包括印度Mahyco-Monsanto Biotech合资企业的董事总经理和生物技术战略董事。Ketkar先生拥有俄克拉荷马州立大学（Oklahoma State University）化学工程硕士学位和新奥尔良大学（University of New Orleans）工商管理硕士学位。
Rajendra Ketkar has served as our president and chief executive officer since May 2016. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a Master of Business Administration from the University of New Orleans.- Rajendra Ketkar自2016年5月起担任公司总裁兼首席执行官。他的职位包括印度Mahyco-Monsanto Biotech合资企业的董事总经理和生物技术战略董事。Ketkar先生拥有俄克拉荷马州立大学（Oklahoma State University）化学工程硕士学位和新奥尔良大学（University of New Orleans）工商管理硕士学位。
- Rajendra Ketkar has served as our president and chief executive officer since May 2016. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a Master of Business Administration from the University of New Orleans.
- Sarah Reiter
Sarah Reiter于2018年3月加入公司，担任首席商务官。在加入Arcadia之前，Reiter女士是STK Bio-AG Technologies的美国国家主管和Bayer CropScience的生物制剂全球产品经理。她此前曾担任AgraQuest公司的营销和通信Vice President，也曾担任Syngenta USA公司的多种职务。Reiter女士拥有加州大学戴维斯分校（University of California，Davis）的英语学士学位和维拉诺瓦商学院（Villanova School of Business）的工商管理硕士学位。
Sarah Reiter joined the Company as our chief commercial officer in March 2018. Prior to joining Arcadia, Ms. Reiter was the USA country head for STK Bio-ag Technologies and Global Product Manager for Biologics for Bayer CropScience. She previously served as vice president of marketing and communications for AgraQuest and served in several positions with Syngenta USA. Ms. Reiter holds a Bachelor’s Degree in English from the University of California, Davis and a Master’s Certificate in Business Administration from the Villanova School of Business.- Sarah Reiter于2018年3月加入公司，担任首席商务官。在加入Arcadia之前，Reiter女士是STK Bio-AG Technologies的美国国家主管和Bayer CropScience的生物制剂全球产品经理。她此前曾担任AgraQuest公司的营销和通信Vice President，也曾担任Syngenta USA公司的多种职务。Reiter女士拥有加州大学戴维斯分校（University of California，Davis）的英语学士学位和维拉诺瓦商学院（Villanova School of Business）的工商管理硕士学位。
- Sarah Reiter joined the Company as our chief commercial officer in March 2018. Prior to joining Arcadia, Ms. Reiter was the USA country head for STK Bio-ag Technologies and Global Product Manager for Biologics for Bayer CropScience. She previously served as vice president of marketing and communications for AgraQuest and served in several positions with Syngenta USA. Ms. Reiter holds a Bachelor’s Degree in English from the University of California, Davis and a Master’s Certificate in Business Administration from the Villanova School of Business.
- Matthew T. Plavan
2012年1月，Matthew T. Plavan被任命公司首席执行官和董事会董事。任命为首席执行官之前，他还担任首席财务官兼执行副总裁，业务开发经理，并同时担任临时首席营运官和首席运营官。2005年5月，Plavan先生加入Cesca，担任首席财务官。加入本公司前，Plavan先生在2002年至2005年之间担任StrionAir公司的首席财务总监，这是一家空气净化产品的研发和营销公司。在此之前，Plavan先生2000年至2002年期间在一家无线设备管理公司--Reason公司（Reason Inc.）担任首席财务总监。1993年至2000年这七年间，Plavan先生曾在麦克森公司（McKesson）和McKesson收购的公司中担财务及运营要职，包括先前在一家持有3亿美元的电子卫生保健事业部担任副财务总监。在此之前，Plavan先生是安永会计师事务所（Ernst & Young LLP）的审计经理和风险咨询经理。 1992年，Plavan先生成为一名执业会计师。Plavan先生在加州大学圣巴巴拉分校（the University of California at Santa Barbara）获得企业经济效益学学士学位。
Matthew T. Plavan has served as our chief financial officer since September 2016. Prior to joining Arcadia, Mr. Plavan served as CFO, COO and CEO of Cesca Therapeutics, Inc., and CFO of Strion Air, Inc. and Reason, Inc. He also held executive finance positions with McKesson Corporation and audit and advisory management positions with Ernst & Young. Mr. Plavan is a certified public accountant and earned a bachelor’s degree in business economics from the University of California, Santa Barbara.- 2012年1月，Matthew T. Plavan被任命公司首席执行官和董事会董事。任命为首席执行官之前，他还担任首席财务官兼执行副总裁，业务开发经理，并同时担任临时首席营运官和首席运营官。2005年5月，Plavan先生加入Cesca，担任首席财务官。加入本公司前，Plavan先生在2002年至2005年之间担任StrionAir公司的首席财务总监，这是一家空气净化产品的研发和营销公司。在此之前，Plavan先生2000年至2002年期间在一家无线设备管理公司--Reason公司（Reason Inc.）担任首席财务总监。1993年至2000年这七年间，Plavan先生曾在麦克森公司（McKesson）和McKesson收购的公司中担财务及运营要职，包括先前在一家持有3亿美元的电子卫生保健事业部担任副财务总监。在此之前，Plavan先生是安永会计师事务所（Ernst & Young LLP）的审计经理和风险咨询经理。 1992年，Plavan先生成为一名执业会计师。Plavan先生在加州大学圣巴巴拉分校（the University of California at Santa Barbara）获得企业经济效益学学士学位。
- Matthew T. Plavan has served as our chief financial officer since September 2016. Prior to joining Arcadia, Mr. Plavan served as CFO, COO and CEO of Cesca Therapeutics, Inc., and CFO of Strion Air, Inc. and Reason, Inc. He also held executive finance positions with McKesson Corporation and audit and advisory management positions with Ernst & Young. Mr. Plavan is a certified public accountant and earned a bachelor’s degree in business economics from the University of California, Santa Barbara.